Infant Bacterial Therapeutics AB (publ)

OM:IBT B Stock Report

Market Cap: SEK 754.4m

Infant Bacterial Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OM:IBT B Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Nov 24BuySEK 17,000Maria EkdahlIndividual500SEK 34.00
02 Sep 24BuySEK 350,000Anthon JahreskogIndividual14,000SEK 25.00
02 Sep 24BuySEK 25,500Maria EkdahlIndividual1,000SEK 25.50
28 May 24BuySEK 14,946Maria EkdahlIndividual156SEK 96.00
17 May 24BuySEK 26,207Anthon JahreskogIndividual270SEK 97.60
13 May 24BuySEK 93,410Margareta HagmanIndividual1,000SEK 93.41
10 May 24BuySEK 222,110Anthon JahreskogIndividual2,450SEK 92.00
10 May 24BuySEK 17,960Eva IdénIndividual200SEK 89.80
04 Mar 24BuySEK 36,792Anthon JahreskogIndividual460SEK 80.00
08 Feb 24BuySEK 94,168Anthon JahreskogIndividual1,000SEK 94.20
28 Dec 23BuySEK 22,246Maria EkdahlIndividual245SEK 90.80

Insider Trading Volume

Insider Buying: IBT B insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IBT B?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders530,7293.94%
Private Companies1,174,6348.72%
General Public3,788,78828.1%
Institutions7,977,26959.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 71.87% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11%
SIX Group AG, Asset Management Arm
1,480,423SEK 82.9m0%1.44%
9.98%
Fourth Swedish National Pension Fund (AP4)
1,344,000SEK 75.3m0%0.03%
8.72%
Annwall & Rothschild Investments Ab
1,174,634SEK 65.8m0%no data
8.32%
Northern Trust Global Investments
1,121,425SEK 62.8m0%no data
4.94%
Keel Capital AB
666,053SEK 37.3m0%9.02%
4.47%
AMF Fonder AB
601,902SEK 33.7m0%0.01%
4.47%
Tredje AP-fonden
601,894SEK 33.7m0%0.01%
4.25%
Premier Fund Managers Ltd.
573,153SEK 32.1m0%0.03%
3.95%
Unionen, Endowment Arm
532,023SEK 29.8m0%0.72%
3.29%
SEB Investment Management AB
443,250SEK 24.8m0%no data
3.04%
Ålandsbanken Asset Management Ab
409,104SEK 22.9m0%1.87%
2.73%
David Dangoor
367,705SEK 20.6m0%no data
0.79%
Staffan Stromberg
106,910SEK 6.0m0%no data
0.57%
Handelsbanken Asset Management
76,687SEK 4.3m0%no data
0.3%
Schroder Investment Management Limited
40,000SEK 2.2m0%no data
0.28%
Marathon Asset Management Limited
37,434SEK 2.1m-21.5%no data
0.25%
FCG Fonder AB
34,284SEK 1.9m0%0.02%
0.18%
Anthon Jahreskog
24,270SEK 1.4m136%no data
0.083%
Anders Kronström
11,194SEK 626.8k0%no data
0.074%
Robert Molander
10,000SEK 560.0k0%no data
0.063%
Skandia Fonder AB
8,432SEK 472.2k0%no data
0.043%
Storebrand Fonder AB,
5,848SEK 327.5k0%no data
0.039%
Margareta Hagman
5,284SEK 295.9k0%no data
0.035%
Maria Ekdahl
4,706SEK 263.5k11.9%no data
0.0074%
Dimensional Fund Advisors LP
1,000SEK 56.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 16:01
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Infant Bacterial Therapeutics AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Taylor FeehleyChardan Capital Markets, LLC